跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Oxonal 40/20 oxycodone hydrochloride/naloxone hydrochloride 40 mg/20 mg modified release tablet blister - TGA Drug Approval Details
Approvals
/
TGA
/
Oxonal 40/20 oxycodone hydrochloride/naloxone hydrochloride 40 mg/20 mg modified release tablet blister
Approved
STANDARD
Oxonal 40/20 oxycodone hydrochloride/naloxone hydrochloride 40 mg/20 mg modified release tablet blister
AU Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
da815ceb6fc75ad6
Company
AU Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
da815ceb6fc75ad6
Product Name
Oxonal 40/20 oxycodone hydrochloride/naloxone hydrochloride 40 mg/20 mg modified release tablet blister
Artg Id
414722
Artg Name
Oxonal 40/20 oxycodone hydrochloride/naloxone hydrochloride 40 mg/20 mg modified release tablet blister
Sponsor
AU Pharma Pty Ltd
Artg Date
2024-04-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
da815ceb6fc75ad6
Type
Standard
Back to TGA Approvals